Professional Documents
Culture Documents
Lmi Reviewer Finals
Lmi Reviewer Finals
37 | F O C
a. access is given only to the
platform that develops that
Benefits of CDR:
specific software
1. Basis for reporting, studying, planning, and b. no access to the servers
supporting clinical research anymore
2. Simplified data processing and analysis c. mas mababaw yung control
3. Improved clinical decision making na meron ka
d. you will be given access to
Challenges of CDR: the platform that can be used
to develop the software
1. Difficult set up/programming
3. Software as a service (SaaS)
a. If you don’t have the suited personal
a. access is given to that
(i.e., IT), you can experience difficulty
specific software only
in setting up/programming your CDR
b. no access to platforms and
2. Privacy issues
servers that powers and runs
a. In cases where clinical data is
the software
obtained then you will use them for a
c. access given is only superficial
different purpose, it could
compromise the privacy /
confidentiality of data
b. Key: to employ a good protocol for
your data; make sure to get the
consent of the people involved if
you’re going to use the data for a
different purpose
Cloud Computing
38 | F O C
c. The company is operating its - simply the delivery of public health or
own cloud but at the same medical services through devices that are
time that cloud is part of a portable/mobile
bigger cloud/system
Goal of Mobile Health
4. Community cloud
a. Similar to public cloud - To share information between the mobile
wherein there are different device and a patient’s electronic medical
clients utilizing that record (EMR)
platform/software
b. There is a common ground Examples of mHealth Apps
between those clients
1. Kardia Mobile
c. Ex.: TLC drive, LMI drive, clients
a. Type of app: remote monitoring app
are all educational institutions
b. Origin country: the USA
Benefits of Cloud Computing: c. Availability: iOS and Android
➢ app that can be used to monitor your
1. Reduction in healthcare expenses through laboratory results and health records
reduced IT infrastructure and maintenance while you are away from your
a. because you are only available physician
services on the internet, you don’t 2. BlueStar Diabetes
need to create your own machines a. Type of app: chronic disease
2. Increased access and flexibility of data management
regardless of differences in systems/platforms b. Origin country: the USA
a. because it is access through the c. Availability: iOS and Android
internet, it is more possible for ➢ goal is to monitor the progress of your
healthcare professionals to access disease (e.g., sugar levels, insulin
the data they need dosage)
3. Reduced carbon emissions compared to 3. Calm
traditional ICT systems = better environmental a. Type of app: mental health app
impact b. Origin country: the USA
a. since different institutions are just c. Availability: iOS and Android
relying on one server, it will reduce ➢ this app would recommend music
the electricity consumed, etc. according to your current mental
state
Challenges of Cloud Computing:
4. Shopwell: Better Food Choices
1. Lack of reliable service cloud service a. Type of app: healthy living apps
providers b. Origin country: the USA
2. Security and privacy issues c. Availability: iOS and Android
a. prone to hacking ➢ utilizes your health record to make
b. information can be leaked recommendations about your diet or
3. Legal issues on property and privacy exercise in order to attain a certain
goal (e.g., weight)
LESSON 12: MOBILE HEALTH 5. WebMD Symptom Checker
a. Type of app: symptom checking app
Mobile health
b. Origin country: the USA
- medical and public health practices c. Availability: iOS and Android
supported by mobile devices such as: (WHO) ➢ very good for individuals who are
o Mobile phones, curious about the symptoms they are
o Patient monitoring devices, experiencing
o Personal digital assistants (PDAs), and 6. PEPID
o Other wireless devices a. Type of app: clinical and diagnostic
apps
39 | F O C
b. Origin country: the USA the app because that is
c. Availability: iOS and Android where the data is encoded
➢ used as a reference tool for ii. Clinical data may be used
healthcare professionals; quick both clinically and
search/google for doctors commercially
7. Appointik iii. Patients would feel the
a. Type of app: practice management benefit of this app because
app the clinical data is now made
b. Origin country: India available and is easier to refer
c. Availability: Android to a physician
➢ equivalent to konsultaMD, apps for iv. The app developers may use
telemedicine, used by doctors and your data to improve their
healthcare professionals to help them software
in their practice through b. Challenge
scheduling/storage for their patients i. Patients are not
compensated for the usage
Benefits and Challenges
of their data
1. Patient access ii. Third-parties are now using
2. Data ownership your data to improve their
3. Privacy and security business
4. Bystanders 3. Privacy and Security
a. Benefit
Benefits and Challenges i. Collection of health is
weaved into the everyday
1. Patient access
routine of the user
a. Benefit
ii. There are some apps that
i. Patients have the opportunity
collect your data
to be active partners in their
automatically (e.g., vital
own health
statistics)
ii. You can see your laboratory
iii. Less hassle because you don’t
results through the mobile
have to manually input your
health app
data
iii. mHealth app would
b. Challenge
encourage patients to be
i. Data collected is only as
more aware of their health
secure as the device itself
status
ii. Data is vulnerable to hacks
iv. You become more conscious
of your health and diet
** Being exposed as someone
b. Challenge
diagnosed with an illness comes with
i. Access to results can provide
real risk. Having that information
opportunity for confusion and
revealed makes one vulnerable to
potential distress
shame and stigma at best,
ii. Patients are pushed to refer to
discrimination and legal
online sources and take
consequences at worst. Most
matters into their own hands
individuals do not wish to keep health
iii. Can cause panic
information private for privacy’s sake.
2. Data ownership
[They] wish to keep their health
a. Benefit
information private from the people
i. Clinical data is owned by the
who have an impact on their lives in
patient because it is his/her
some way, people who have the
own clinical data but at the
capacity to influence their social or
same time is also owned by
legal standing of the subject.
40 | F O C
4. Bystanders LESSON 13: MOLECULAR LABORATORY
a. Bystanders – third-party individuals
who did not consent to having their Reverse Transcription Polymerase Chain Reaction
information collected or stored - reversing RNA to DNA before you perform
b. Challenge PCR
i. Bystanders are put at legal or - DNA = deoxyribonucleic acid
personal risk - RNA = ribonucleic acid
ii. Non-maleficence and - Thermocycler – machine used in RT-PCR
autonomy principles are
violated Physical Requirements and Workflow
iii. Being a bystander has no
- Main goal: To prevent contamination
benefit on their side
o E.g., mixture of DNA with the reagents
iv. Having bystanders in your
that may cause faulty results,
mobile health app can be
contamination between sample 1
difficult/challenging because
and sample 2, exposure to
these bystanders do not
environment where they will be easily
receive any benefit from the
degraded
app instead they are at risk for
- Polymerase chain reaction
disclosing their clinical
o (Most) common molecular technique
information to the public
performed
Current State of mHealth o Easily susceptible to contamination
o Examples:
Reasons for using mHealth applications: ▪ Sample to sample
1. Simplicity and low cost ▪ Previous to current cycle
2. User-friendly service ▪ Cross-contamination of
3. Enhanced speed and accuracy of different reactions
healthcare delivery ▪ Contamination of reagents
with DNA templates
Current uses of mHealth apps:
Main procedures performed in PCR
1. Medication adherence and compliance aid
2. Remote data collection 1. Pre-PCR
3. Access to patient record a. Sample preparation
4. Access to health information database b. PCR preparation
5. Census taking i. DNA extractions from swabs,
6. EHR creation and storage reagent preparation,
creating your PCR mix
Future Direction ** both performed in a clean area (there
are very little/no contaminants yet)
• Usage of 5G technology
2. Post-PCR
• Increase global usage
a. Performing PCR
• Rise of complex, voluminous and multi-
i. actual performing of PCR
dimensional mobile health data
b. Post-PCR analysis
Challenges related to the Future of mHealth: i. analysis of your amplicons or
products such as
1. Lack of ICT infrastructure – lack of coverage electrophoresis, putting dye
and quality of internet providers for visualization
2. Lack of financial resources – lack of resources ** both performed in a dirty area
to computerize the health system
3. Lack of education Recommended Rooms
4. Security and privacy issues
1. Reagent preparation
5. Neglect of technological problems
2. Sample preparation
41 | F O C
3. PCR step / Amplification room ▪ Negative pressure: post-PCR
4. Post-PCR step rooms (the pressure is lower
inside the room compared to
Alternatives
outside; direction of air:
5. Separate benches/working areas outside inside)
6. Separate processing time o UV irradiation
▪ Used to sterilize the pre-PCR
laboratory
Biosafety cabinet
Thermocycler
Quality Assessment
43 | F O C
o Research Institute for Tropical iv. PCR
Medicine (RITM) – National reference v. Clerical activities
laboratory for COVID testing b. Must follow the unidirectional flow
3. Equipment and Instruments
DOH Local Guidelines
a. Proper placement of equipment in
• DOH AO 2020-0014 designated areas
o Specific Guidelines b. Documented inventory of
1. Personnel equipment, supplies, reagents, and
2. Physical Facilities control
3. Equipment and Instruments c. Periodic calibration and
4. Service Capability maintenance of equipment
5. Quality Improvement d. Daily cleaning and maintenance
Activities 4. Service Capability
6. Information Management a. Manual of Procedures, Work
7. Environmental Management Instructions, Standard Operating
8. Contingency Plan Procedures
9. Release of Results b. RITM Biosafety Guidelines
1. Personnel i. the laboratory should comply
a. Minimum number of personnel: Seven with these biosafety
(7) guidelines to protect the
i. 1 pathologist workers from infection
ii. 3 full-time analyst 5. Quality Improvement Activities
▪ 3 MTs or a. RITM proficiency testing
▪ 2 MTs and 1 allied b. RITM NEQAS
health graduate 6. Information Management
iii. 1 full-time laboratory aide a. Adherence to Data Privacy Act of
iv. 1 full-time receptionist 2012: RA 10173
v. 1 full-time encoder b. COVID: RA 11332 - Mandatory
b. Required trainings Reporting of Notifiable Diseases and
i. Biosafety and Biosecurity Health Events of Public Health
▪ Biosafety – protecting Concern Act
people from c. Proper documentation through
pathogenic organisms logbooks
▪ Biosecurity – 7. Environmental Management
protecting a. focuses on making sure that the
microorganisms from wastes generated by the laboratory
bad people / are disposed properly
malicious use b. proper management of hazardous
ii. Molecular Diagnostics and toxic waste
▪ RITM provides c. decontamination measures before
proficiency training for disposing them as regular wastes
molecular diagnostics 8. Contingency Plan
▪ you should have your a. focuses on a backup plan in case the
certification before machine is broken, or the laboratory
you can be hired in a cannot perform the services
molecular laboratory b. Memorandum of Agreement /
2. Physical Facilities partnership with other laboratories
a. Dedicated spaces 9. Release of Results
i. Specimen reception a. Signatories:
ii. Reagent storage and i. RMT
handling ii. Senior MT for verification
iii. Pre-PCR iii. Pathologist for approval
44 | F O C
10. Validity of DOH-LTO
a. Validity of the License to Operate of
a COVID-19 testing laboratory in the
Philippines: One year
11. Regulating/Monitoring Agencies
a. Health Facilities and Services and
Regulatory Bureau (HFSRB)
b. Center for Health Development
(CHD)
c. Research Institute of Tropical
Medicine
i. PH’s reference laboratory for
COVID-19 testing
d. Epidemiology Bureau
e. Regulating agencies that monitor
clinical laboratories
45 | F O C